Seno Medical Uses Laser-Based Technology For Early cancer Diagnosis
Seno Medical is a company focused on cancer using its new patented opto-acoustic technology. This new imaging modality combines the use of light in and […]
diagnostics
Axial Biotech Has Developed the First Scoliosis Prognostic Test
Scoliosis is a degenerative spinal cord disease that leads to painful and debilitating spinal curvature, and this condition has a high-need for comprehensive diagnostics. Axial […]
CleveMed Develops Physiological Monitoring System To Measure Disease Progression
A difficult to asses and important clinical manifestation of the progression of neuromuscular-degenerative disorders, such as Parkinson’s, is the extent which the patient has lost […]
Dialog Devices Limited Uses Opto-Electronics To Measure Blood Supply
Dialog Devices Limited is a medical devices company that has developed the first fully automated, non-invasive apparatus for assessment of blood supply to the lower […]
DxNA Amplifies Genetic Material to Detect Disease
DxNA is medical devices company that uses the amplification of genetic material for the diagnostic identification of diseases, microbes, or genetic disorders. The company has […]
Diagnostics and Personalized Medicine Panel Selected in OneMedForum SF 2011
Advances in molecular biology now make it possible to detect diseases sooner, allowing physicians to advise patients on optimal therapies. The Diagnostics and Personalized Medicine panel explores the changing world of diagnostics, bringing together executives, experienced venture capitalists, and a physician.
DPR’s CaseReader Poised to Break New Ground in Diagnostic Radiology
DataPhysics Research (DPR) of Danville, CA, has developed a turnkey software solution to improve the quality of image-based diagnostics and ease the workload of radiologists.
Blood Tests Can Enable Early Cancer Diagnosis
Scientists have yet to find the magic cure for cancer, but they may have found a way to beat it at its own game.
GE Healthcare to Acquire Diagnostics Company Clarient
General Electric announced Friday that its healthcare unit will acquire molecular diagnostics company Clarient in a deal worth approximately $580 million.
Ortho Kinematics Pursues Large Market Opportunity in Back Pain Diagnostics
Although back pain is common, it can be difficult for physicians to determine the exact cause of the pain using current testing methods.